Section 1002.20(3), Florida Statutes, was amended to add self-administration of pancreatic enzyme medication by students with cystic fibrosis (SB 166) as well as management of students with diabetes (HB 747). The approved legislation requires rulemaking in cooperation with the Florida Department of Health (FDOH). Therefore, Rule 6A-6.0251, F.A.C., is being amended in cooperation with FDOH to define terminology and to address management of students with certain health conditions. The rule title is being changed to include inhaler use by students with asthma, the use of epinephrine auto-injectors by students with life-threatening allergies, use of pancreatic enzyme medication by students with cystic fibrosis, and management of students with diabetes.